131 related articles for article (PubMed ID: 34619698)
21. Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma.
Guang Y; Luo Y; Zhang Y; Zhang M; Li N; Zhang Y; Tang J
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1555-1562. PubMed ID: 28342000
[TBL] [Abstract][Full Text] [Related]
22. Radiofrequency ablation for treatment of locally recurrent thyroid cancer presenting as a metastatic lymph node with dense macrocalcification: A case report and literature review.
Yoo RE; Kim JH; Paeng JC; Park YJ
Medicine (Baltimore); 2018 Mar; 97(9):e0003. PubMed ID: 29489641
[TBL] [Abstract][Full Text] [Related]
23. [Treatment strategy of papillary thyroid carcinoma for the unmarried woman].
Nagashima S; Sakurai K; Fujisaki S; Suzuki S; Shibata M; Tomita R; Hara Y; Matsumoto K; Enomoto K; Amano S
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2002-4. PubMed ID: 22202265
[TBL] [Abstract][Full Text] [Related]
24. Axillary lymph node metastasis of papillary thyroid carcinoma detected by FDG PET/CT in a thyroglobulin-positive patient with negative whole-body 131I scan.
Elboga U; Kalender E; Yilmaz M; Celen YZ; Aktolun C
Clin Nucl Med; 2012 Nov; 37(11):1120-2. PubMed ID: 22996245
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes and prognostic factors of radioiodine ablation therapy for lymph node metastases from papillary thyroid carcinoma.
Wu X; Gu H; Gao Y; Li B; Fan R
Nucl Med Commun; 2018 Jan; 39(1):22-27. PubMed ID: 29135721
[TBL] [Abstract][Full Text] [Related]
26. [Clinical study on papillary thyroid carcinoma presenting with lymph node metastasi].
Mizumachi T; Oridate N; Homma A; Nagahashi T; Furuta Y; Fukuda S
Nihon Jibiinkoka Gakkai Kaiho; 2004 Aug; 107(8):750-5. PubMed ID: 15457986
[TBL] [Abstract][Full Text] [Related]
27. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
28. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
29. Lymph Node Dissection for Papillary Thyroid Carcinoma.
Lo CY
Methods Mol Biol; 2022; 2534():57-78. PubMed ID: 35670968
[TBL] [Abstract][Full Text] [Related]
30. Papillary thyroid carcinoma in a 3-year-old child: case report.
Alkan S; Seven H; Sakalli E; Dadaş B
Int J Pediatr Otorhinolaryngol; 2008 Feb; 72(2):275-7. PubMed ID: 18061281
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up.
Ito Y; Kudo T; Kobayashi K; Miya A; Ichihara K; Miyauchi A
World J Surg; 2012 Jun; 36(6):1274-8. PubMed ID: 22270990
[TBL] [Abstract][Full Text] [Related]
32. Parameters Influencing Curative Effect of 131I Therapy on Pediatric Differentiated Thyroid Carcinoma: A Retrospective Study.
Xu L; Liu Q; Liu Y; Pang H
Med Sci Monit; 2016 Aug; 22():3079-85. PubMed ID: 27576533
[TBL] [Abstract][Full Text] [Related]
33. Identification of a neck lump as a lymph node metastasis from an occult contralateral papillary microcarcinoma of the thyroid: key role of thyroglobulin assay in the fine-needle aspirate.
Bruno R; Giannasio P; Chiarella R; Capula C; Russo D; Filetti S; Costante G
Thyroid; 2009 May; 19(5):531-3. PubMed ID: 19416000
[TBL] [Abstract][Full Text] [Related]
34. Papillary thyroid carcinoma arising from a thyroglossal duct cyst: a single institution experience.
Choi YM; Kim TY; Song DE; Hong SJ; Jang EK; Jeon MJ; Han JM; Kim WG; Shong YK; Kim WB
Endocr J; 2013; 60(5):665-70. PubMed ID: 23318645
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V
Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581
[TBL] [Abstract][Full Text] [Related]
36. [Prospective therapy study in differentiated thyroid carcinoma].
Gemsenjäger E; Heitz P; Martina B
Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
[TBL] [Abstract][Full Text] [Related]
37. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer.
Hughes DT; White ML; Miller BS; Gauger PG; Burney RE; Doherty GM
Surgery; 2010 Dec; 148(6):1100-6; discussion 1006-7. PubMed ID: 21134539
[TBL] [Abstract][Full Text] [Related]
38. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
[TBL] [Abstract][Full Text] [Related]
39. Cervical lymph node metastases in papillary thyroid cancer: Preoperative staging with ultrasound and/or computed tomography.
Lu G; Chen L
Medicine (Baltimore); 2022 Mar; 101(9):e28909. PubMed ID: 35244044
[TBL] [Abstract][Full Text] [Related]
40. Solitary focus in the liver in a thyroid cancer patient after a whole body scan with 131 iodine.
Pena Pardo FJ; Crespo de la Jara A; Fernández Morejón FJ; Sureda González M; Forteza Vila J; Brugarolas Masllorens A
Rev Esp Med Nucl; 2007; 26(5):294-6. PubMed ID: 17910838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]